The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year ...
The FDA has granted 501 (k) clearance to the EXENT® System, a fully automated device for assessing monoclonal gammopathies, ...
The executive who brought Novo Nordisk A/S’s first weight-loss shot to market is coming back as chairman of the Danish drugmaker, and not all shareholders are happy about it.
Today, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this ...
A minority of patients see stalled progress - or no progress at all - and the reasons range from medication issues to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback